Is Any Patient with Chronic Heart Failure Receiving the Right Dose of the Right Beta-Blocker in Primary Care?
Author:
- 1 November 2019
- journal article
- editorial
- Published by Elsevier in The American Journal of Medicine
- Vol. 132 (11) , e761-e762
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Medical Therapy for Heart Failure With Reduced Ejection FractionJACC, 2018
- Does a Target Dose or a Target Heart Rate Matter to Outcomes When Prescribing β-Blockers to Patients With Chronic Heart Failure?Circulation: Cardiovascular Quality and Outcomes, 2018
- Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart FailureJACC, 2017
- Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection FractionCirculation: Heart Failure, 2017
- Should β-Blockers Be Used in Patients With Heart Failure and Atrial Fibrillation?Clinical Therapeutics, 2015
- Long-Term Functional and Clinical Follow-Up of Patients With Heart Failure With Recovered Left Ventricular Ejection Fraction After β-Blocker TherapyCirculation: Heart Failure, 2014
- Ventricular Rate Control of Atrial Fibrillation in Heart FailureHeart Failure Clinics, 2013
- Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart FailureJACC, 2012
- Differences Between Beta-Blockers in Patients With Chronic Heart Failure and Chronic Obstructive Pulmonary DiseaseJACC, 2010
- Prognostic benefit of beta-blockers in patients not receiving ACE-InhibitorsEuropean Heart Journal, 2005